logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11014935 B1

PDFFull Text
Expired
Date of Patent:
May. 25, 2021

Filed:

Jun. 20, 2017

Compounds for the treatment of paramyxovirus viral infections

Applicant:

Janssen Biopharma, Inc., South San Francisco, CA (US);

Inventors:

Guangyi Wang, Carlsbad, CA (US);

Leonid Beigelman, San Mateo, CA (US);

Anh Truong, Burlingame, CA (US);

Carmela Napolitano, Verona, IT;

Daniele Andreotti, Verona, IT;

Haiying He, Shanghai, CN;

Assignee:

Janssen BioPharma, Inc., South San Francisco, CA (US);

Attorney:

Morrison & Foerster LLP

Primary Examiner:

Patricia L Morris

Int. Cl.
CPC ...
C07D 409/04 (2006.01); C07D 495/04 (2006.01); C07D 333/58 (2006.01); C07D 215/12 (2006.01); C07D 215/14 (2006.01); C07D 311/68 (2006.01); C07D 215/42 (2006.01); C07D 217/24 (2006.01); C07D 333/16 (2006.01); C07D 333/20 (2006.01); C07D 233/38 (2006.01); C07D 333/50 (2006.01); C07D 333/54 (2006.01); C07D 233/61 (2006.01); C07D 333/62 (2006.01); C07D 333/66 (2006.01); C07D 333/68 (2006.01); C07D 335/06 (2006.01); C07D 233/88 (2006.01); C07D 401/04 (2006.01); C07D 401/10 (2006.01); C07D 401/12 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 409/14 (2006.01); C07D 413/04 (2006.01); C07D 413/12 (2006.01); C07D 417/04 (2006.01); C07D 417/12 (2006.01); C07D 471/04 (2006.01); C07D 261/20 (2006.01); C07D 207/335 (2006.01); C07D 209/08 (2006.01); C07D 209/14 (2006.01); C07D 277/64 (2006.01); C07D 209/86 (2006.01); C07D 213/42 (2006.01); C07D 213/50 (2006.01); C07D 213/65 (2006.01); C07D 213/68 (2006.01); C07D 307/52 (2006.01); C07D 307/81 (2006.01); C07D 233/60 (2006.01); C07D 495/14 (2006.01); C07C 251/84 (2006.01); A61K 45/06 (2006.01); A61K 31/381 (2006.01); A61K 31/404 (2006.01); A61K 31/407 (2006.01); A61K 31/4155 (2006.01); A61K 31/4418 (2006.01); A61K 31/4439 (2006.01); A61K 31/444 (2006.01); A61K 31/506 (2006.01); C07C 243/34 (2006.01); C07C 251/80 (2006.01); C07C 255/34 (2006.01); A61K 31/4164 (2006.01); A61K 31/426 (2006.01); A61K 31/4436 (2006.01); A61K 31/496 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/5377 (2006.01); C07D 209/20 (2006.01); C07D 233/64 (2006.01); C07D 277/56 (2006.01); C07D 409/06 (2006.01); C07D 409/12 (2006.01); A61K 31/165 (2006.01); A61K 31/277 (2006.01); A61K 31/341 (2006.01); A61K 31/343 (2006.01); A61K 31/352 (2006.01); A61K 31/382 (2006.01); A61K 31/40 (2006.01); A61K 31/4025 (2006.01); A61K 31/4196 (2006.01); A61K 31/423 (2006.01); A61K 31/427 (2006.01); A61K 31/428 (2006.01); A61K 31/4365 (2006.01); A61K 31/4375 (2006.01); A61K 31/4427 (2006.01); A61K 31/4545 (2006.01); A61K 31/47 (2006.01); A61K 31/4704 (2006.01); A61K 31/4709 (2006.01); A61K 31/4725 (2006.01); A61K 31/538 (2006.01); C07C 243/18 (2006.01); C07C 255/66 (2006.01); C07D 215/38 (2006.01); C07D 307/40 (2006.01); C07D 307/91 (2006.01); C07D 333/76 (2006.01); C07D 405/10 (2006.01); C07D 413/14 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); A61K 31/165 (2013.01); A61K 31/277 (2013.01); A61K 31/341 (2013.01); A61K 31/343 (2013.01); A61K 31/352 (2013.01); A61K 31/381 (2013.01); A61K 31/382 (2013.01); A61K 31/40 (2013.01); A61K 31/404 (2013.01); A61K 31/407 (2013.01); A61K 31/4025 (2013.01); A61K 31/4155 (2013.01); A61K 31/4164 (2013.01); A61K 31/4196 (2013.01); A61K 31/423 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 31/428 (2013.01); A61K 31/4365 (2013.01); A61K 31/4375 (2013.01); A61K 31/444 (2013.01); A61K 31/4418 (2013.01); A61K 31/4427 (2013.01); A61K 31/4436 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/47 (2013.01); A61K 31/4704 (2013.01); A61K 31/4709 (2013.01); A61K 31/4725 (2013.01); A61K 31/496 (2013.01); A61K 31/497 (2013.01); A61K 31/501 (2013.01); A61K 31/506 (2013.01); A61K 31/538 (2013.01); A61K 31/5377 (2013.01); A61K 45/06 (2013.01); C07C 243/18 (2013.01); C07C 243/34 (2013.01); C07C 251/80 (2013.01); C07C 251/84 (2013.01); C07C 255/34 (2013.01); C07C 255/66 (2013.01); C07D 207/335 (2013.01); C07D 209/08 (2013.01); C07D 209/14 (2013.01); C07D 209/20 (2013.01); C07D 209/86 (2013.01); C07D 213/42 (2013.01); C07D 213/50 (2013.01); C07D 213/65 (2013.01); C07D 213/68 (2013.01); C07D 215/12 (2013.01); C07D 215/14 (2013.01); C07D 215/38 (2013.01); C07D 215/42 (2013.01); C07D 217/24 (2013.01); C07D 233/38 (2013.01); C07D 233/60 (2013.01); C07D 233/61 (2013.01); C07D 233/64 (2013.01); C07D 233/88 (2013.01); C07D 261/20 (2013.01); C07D 277/56 (2013.01); C07D 277/64 (2013.01); C07D 307/40 (2013.01); C07D 307/52 (2013.01); C07D 307/81 (2013.01); C07D 307/91 (2013.01); C07D 311/68 (2013.01); C07D 333/16 (2013.01); C07D 333/20 (2013.01); C07D 333/50 (2013.01); C07D 333/54 (2013.01); C07D 333/58 (2013.01); C07D 333/62 (2013.01); C07D 333/66 (2013.01); C07D 333/68 (2013.01); C07D 333/76 (2013.01); C07D 335/06 (2013.01); C07D 401/04 (2013.01); C07D 401/10 (2013.01); C07D 401/12 (2013.01); C07D 405/04 (2013.01); C07D 405/10 (2013.01); C07D 405/12 (2013.01); C07D 409/04 (2013.01); C07D 409/06 (2013.01); C07D 409/12 (2013.01); C07D 409/14 (2013.01); C07D 413/04 (2013.01); C07D 413/12 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01); C07D 495/14 (2013.01); C07C 2602/08 (2017.05);
Abstract

Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

Find Patent Forward Citations

Wang, Guangyi. (2021). Compounds for the treatment of paramyxovirus viral infections (U.S. Patent No. 11014935). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11014935

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…